Skip to main content

Featured

Shopify Just Pushed the TSX to a Record — Should You Be Buying, or Is It Too Late?

  Published August 6, 2026 If you glanced at the markets on Wednesday and saw the TSX hit another record high, there's a good chance one company did most of the heavy lifting: Shopify. The S&P/TSX Composite closed up 344.83 points, or 1%, at 36,146.42 on August 5 — its second straight record close. Shopify shares jumped 16.5%, their biggest one-day move in a year, after the Ottawa-based e-commerce company beat earnings expectations and issued a stronger-than-expected outlook for the rest of the year. Gold miners added to the rally too, as bullion prices climbed. What It Means for You: If you own a Canadian equity index fund or ETF in your RRSP or TFSA, you almost certainly own a slice of this move already — whether you meant to or not. What actually happened Shopify reported second-quarter revenue of $3.58 billion (U.S.), up 34% from a year earlier and well ahead of the roughly $3.45 billion analysts expected. Adjusted earnings came in at $0.42 a share versus the $0.40 expecte...
Post a Comment
Read more

article

Labels

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.

  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.

  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.

  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.

  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Labels:

Comments

Post a Comment